Peter Attia· MD
and then the perversity 3 is telling you how much peripheral t4 is being converted to reverse t3 which opposes t3
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and then the perversity 3 is telling you how much peripheral t4 is being converted to reverse t3 which opposes t3
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
reverse T3 is very similar to T3 except for a very important difference which is it doesn't activate the receptor that T3 activates so it occupies the receptor without activating it so in effect you can think of reverse T3 as anti-t3 it basically blocks the effects of T3